When health risks go down, worker productivity goes up Changes in employee health risk factors have a significant impact on work productivity, reports a new study. The productivity benefits of improved health are "cumulative over time," highlighting the need for companies to make "continuous investments in the culture of health," according to the study
Poison center warns against designer drug 'N-bomb’ The relatively new synthetic drug 25I-NBOMe, or “N bomb,” has been associated with the deaths of at least 17 people in the United States since 2010, when it became available over the Internet,
Microbes help produce serotonin in gut Although serotonin is well known as a brain neurotransmitter, it is estimated that 90 percent of the body's serotonin is made in the digestive tract. In fact, altered levels of this peripheral serotonin has been linked to diseases such as irritable bowel syndrome, cardiovascular disease, and osteoporosis.
Drug regulations tied to fewer prescriptions of effective gout drug Well intentioned, but costly and potentially problematic. That's how researchers describe the end result of a decision by the Food and Drug Administration (FDA) to regulate colchicine, a drug used to treat gout, among other ailments. Fewer patients are actually now taking it, and it has come at a cost to their wallets. Colchicine had been sold at low cost for many years in the US. It is widely used to treat gout,
Novel tissue substitute made of high-tech fibers Regenerative medicine uses cells harvested from the patient’s own body to heal damaged tissue. Researchers have developed a cell-free substrate containing proteins to which autologous cells bind and grow only after implantation
No comments:
Post a Comment